SafeBeat GTM brain

category

market profile

• text: Cardiac practices need to review ECG data and manage medication monitoring without overwhelming clinicians with alerts.
• text: The home page describes its product as investigational and not currently for sale; an FDA 510(k) summary describes a SafeBeat Rx App, so current product availability and scope require verification.

personas

• title: Cardiac electrophysiologist
  pains:

  • Monitoring rhythm and drug initiation while managing limited clinical time
  • Finding actionable ECG information amid alerts
• title: Cardiology service line leader
  pains:

  • Scaling cardiac monitoring workflows
  • Expanding patient access to specialist-led care
• title: Digital cardiac device product leader
  pains:

  • Building reliable ECG interpretation and clinician workflows into a product
  • Integrating third-party monitoring with usable therapeutic insights

icp

• text: US cardiology practices, health systems and electrophysiology programs treating rhythm disorders.
• text: Cardiac monitoring or digital health companies seeking ECG analytics for their products.
• text: Enterprise cardiology networks evaluating remote monitoring workflows.

message pillars

• text: Move from diagnosis toward treatment guidance.
• text: Build the workflow around clinical users.
• text: Reduce alert burden and surface information.
• text: Enable mobile cardiac therapeutic workflows.

objections

• objection: Is it available for clinical purchase?
  response: The website says the product is under development and investigational. Confirm the current regulatory status and specific offering directly before procurement.
• objection: Does this replace clinical judgment?
  response: The described software is designed to present diagnostic information and patient-specific treatment steps to clinicians.
• objection: Does it require a proprietary monitor?
  response: SafeBeat describes using third-party FDA-cleared cardiac monitoring devices; verify compatibility for the intended workflow.

competitors

• name: AliveCor
  why: Offers mobile ECG devices and AI-enabled cardiac rhythm analysis, with overlapping monitoring use cases.
• name: Tricog Health
  why: Provides AI ECG analysis and remote cardiac care tools.

influencers

• name: Rachita Navara
  url: https://safebeat.com/about/
  why: Founder, CEO and electrophysiologist.
• name: Sanjiv Narayan
  url: https://safebeat.com/about/
  why: Stanford arrhythmia expert and listed advisor.

keywords

• AI ECG interpretation
• remote cardiac monitoring
• antiarrhythmic drug monitoring
• atrial fibrillation treatment software
• QT interval monitoring
• cardiac therapeutic monitoring

voice

• clinical
• mission-driven
• research-oriented

signals

• text: A cardiology network seeks remote workflows for cardiac medication monitoring.
• text: A monitoring device vendor seeks ECG analysis software for its product.

stack

• Third-party cardiac monitoring devices

hiring

• Head of Growth
• Certified Cardiac Technician
• Regulatory Affairs Interns

pricing

motion

channels

• clinical conferences
• research publications
• partnerships
• outbound

confidence

Founders

• name: Rachita Navara
  title: Founder
  role: Founder
  bio: Dr. Navara is an EP cardiologist and bioengineer internationally recognized for her contributions to heart rhythm research and medical innovation. While caring for patients in the hospital, she identified the need to expand access to patients starting heart drugs. To solve this problem, she assembled a multi-disciplinary team including heart rhythm physicians, data scientists, AI engineers, clinical trialists, and regulatory experts. Her passion is to use engineering to transform heart health.